Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

V. Wee Yong, Rana K. Zabad, Smriti Agrawal, Angelika Goncalves DaSilva, Luanne M. Metz

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS). This review summarizes the consequences of upregulation of MMP members in MS as well as in an animal model of the disease, experimental autoimmune encephalomyelitis (EAE). The pathogenic roles of MMPs are considered, especially in the transmigration of leukocytes into the CNS. We review the evidence that interferon-beta, an immunomodulator that is commonly used in MS, affects MMP expression in the disease. The potential of minocycline as a therapy in MS, based on its activity as an MMP inhibitor, is discussed. Besides affecting MMPs, minocycline may have other actions that help account for its possible utility in MS.

Original languageEnglish (US)
Pages (from-to)79-84
Number of pages6
JournalJournal of the neurological sciences
Volume259
Issue number1-2
DOIs
StatePublished - Aug 15 2007

Fingerprint

Immunologic Factors
Matrix Metalloproteinases
Multiple Sclerosis
Minocycline
Animal Disease Models
Matrix Metalloproteinase Inhibitors
Autoimmune Experimental Encephalomyelitis
Interferon-beta
Leukocytes
Up-Regulation
Pathology

Keywords

  • EAE
  • Interferon-beta
  • Metalloproteinases
  • Minocycline
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. / Yong, V. Wee; Zabad, Rana K.; Agrawal, Smriti; Goncalves DaSilva, Angelika; Metz, Luanne M.

In: Journal of the neurological sciences, Vol. 259, No. 1-2, 15.08.2007, p. 79-84.

Research output: Contribution to journalArticle

Yong, V. Wee ; Zabad, Rana K. ; Agrawal, Smriti ; Goncalves DaSilva, Angelika ; Metz, Luanne M. / Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. In: Journal of the neurological sciences. 2007 ; Vol. 259, No. 1-2. pp. 79-84.
@article{8819712b2088440db7705929ba26e439,
title = "Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators",
abstract = "The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS). This review summarizes the consequences of upregulation of MMP members in MS as well as in an animal model of the disease, experimental autoimmune encephalomyelitis (EAE). The pathogenic roles of MMPs are considered, especially in the transmigration of leukocytes into the CNS. We review the evidence that interferon-beta, an immunomodulator that is commonly used in MS, affects MMP expression in the disease. The potential of minocycline as a therapy in MS, based on its activity as an MMP inhibitor, is discussed. Besides affecting MMPs, minocycline may have other actions that help account for its possible utility in MS.",
keywords = "EAE, Interferon-beta, Metalloproteinases, Minocycline, Multiple sclerosis",
author = "Yong, {V. Wee} and Zabad, {Rana K.} and Smriti Agrawal and {Goncalves DaSilva}, Angelika and Metz, {Luanne M.}",
year = "2007",
month = "8",
day = "15",
doi = "10.1016/j.jns.2006.11.021",
language = "English (US)",
volume = "259",
pages = "79--84",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators

AU - Yong, V. Wee

AU - Zabad, Rana K.

AU - Agrawal, Smriti

AU - Goncalves DaSilva, Angelika

AU - Metz, Luanne M.

PY - 2007/8/15

Y1 - 2007/8/15

N2 - The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS). This review summarizes the consequences of upregulation of MMP members in MS as well as in an animal model of the disease, experimental autoimmune encephalomyelitis (EAE). The pathogenic roles of MMPs are considered, especially in the transmigration of leukocytes into the CNS. We review the evidence that interferon-beta, an immunomodulator that is commonly used in MS, affects MMP expression in the disease. The potential of minocycline as a therapy in MS, based on its activity as an MMP inhibitor, is discussed. Besides affecting MMPs, minocycline may have other actions that help account for its possible utility in MS.

AB - The matrix metalloproteinases (MMPs) are implicated in the pathology of multiple sclerosis (MS). This review summarizes the consequences of upregulation of MMP members in MS as well as in an animal model of the disease, experimental autoimmune encephalomyelitis (EAE). The pathogenic roles of MMPs are considered, especially in the transmigration of leukocytes into the CNS. We review the evidence that interferon-beta, an immunomodulator that is commonly used in MS, affects MMP expression in the disease. The potential of minocycline as a therapy in MS, based on its activity as an MMP inhibitor, is discussed. Besides affecting MMPs, minocycline may have other actions that help account for its possible utility in MS.

KW - EAE

KW - Interferon-beta

KW - Metalloproteinases

KW - Minocycline

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=34447104602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447104602&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2006.11.021

DO - 10.1016/j.jns.2006.11.021

M3 - Article

C2 - 17382965

AN - SCOPUS:34447104602

VL - 259

SP - 79

EP - 84

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -